Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Sponsor
MedImmune LLC (Industry)
Overall Status
Completed
CT.gov ID
NCT00384462
Collaborator
(none)
346
59
15
5.9
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to describe respiratory syncytial virus (RSV) hospitalization rates and to begin to address the utilization of outpatient resources for RSV medically-attended lower respiratory tract infections (MALRI) in 32-35 week gestational age (GA) premature infants who are less than 6 months of age and do not receive treatment.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The goals of this study are:
    • To estimate the incidence of hospitalization attributable to RSV within 150 days from enrollment in premature infants who are:

    • 32-35 weeks GA

    • less than 6 months of age at the start of the RSV season

    • not receiving palivizumab prophylaxis and not recommended to receive palivizumab according to the AAP guidelines

    • To estimate the incidence rate of hospitalization attributable to RSV in the other relevant study populations and time periods (e.g., Cohort 2, Cohorts 1 and 2 combined, and subgroups based on chronological age at the start of the RSV season, GA, etc. within 150 days from enrollment and other time periods based on RSV activity, etc.)

    • To estimate the incidence of RSV-associated MALRI in the study populations

    • To characterize the incidence and type of clinical interventions for MALRI in the study populations

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    346 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Prospective, Non-Interventional Study to Evaluate the Incidence of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALRI) in Premature Infants 32 to 35 Weeks Gestational Age Who Are Not Recommended to Receive Prophylaxis for RSV
    Study Start Date :
    Oct 1, 2006
    Actual Primary Completion Date :
    Nov 1, 2007
    Actual Study Completion Date :
    Jan 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Premature Infants (32-35 wks. GA) who are less than six months of age at start of RSV season and followed until May of the following year.

    2

    Premature newborns (32-35 wks. GA) who are born during the current RSV season and discharged from the hospital after 01 Dec and followed until May of the next year.

    Outcome Measures

    Primary Outcome Measures

    1. Estimate the incidence of hospitalization attributable to RSV within 150 days from enrollment in premature infants [150 days from enrollment]

    Secondary Outcome Measures

    1. Estimate the incidence rate of hospitalization attributable to RSV in the other relevant study populations [150 days after enrollment]

    2. Estimate the incidence rate of MALRI attributable to RSV in the study populations; [during follow up]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 6 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Parent/legal guardian able to understand and provide written informed consent

    • Male or female infants born at 32-35 weeks GA. GA will be determined according to available medical records.

    • Clinically stable, in the opinion of the investigator

    • Ability and willingness of the subject's parent/legal guardian to complete all protocol mandated follow-up telephone calls, visits and procedures

    • Not more than one of the following American Academy of Pediatrics (AAP)-defined risk factors:

    1. Childcare attendance

    2. School-aged siblings in the home

    3. Exposure to environmental air pollutants (not including passive exposure to tobacco smoke)

    4. Congenital abnormalities of the airways

    5. Severe neuromuscular disease, as determined by the investigator

    • Subject must meet the criteria listed below for either Cohort 1 or Cohort 2:

    Cohort 1

    • Date of enrollment between 01/Oct and 15/Dec

    • Chronological age of < 6 months (i.e., has not yet reached 6-month birthday) at the traditional start of the local RSV season (as used to determine eligibility for RSV prophylaxis)

    Cohort 2

    • Date of enrollment between 16/Dec and 15/Feb

    • Born during the current RSV season and discharged from the hospital nursery after 01/Dec

    Exclusion Criteria:
    • Previous (within 90 days of enrollment) or concurrent treatment with palivizumab or RSV-IGIV or IVIG

    • Hospitalization at the time of enrollment (unless discharge is anticipated within 10 days)

    • Two or more AAP-defined risk factors as listed under Inclusion Criteria

    • Participation in trials of investigational RSV prophylaxis or therapeutic agents

    • Confirmed prior or current RSV infection (a child with current signs/symptoms of respiratory infection must have negative RSV testing)

    • Diagnosis of chronic lung disease (CLD) of prematurity (formerly referred to as bronchopulmonary dysplasia [BPD])

    • Diagnosis of hemodynamically significant congenital heart disease (CHD), defined as requiring medication or supplemental oxygen for their CHD

    • Known immunodeficiency

    • Life expectancy of < 6 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama at Birmingham Birmingham Alabama United States 35233
    2 Central Arkansas Pediatric Clinic, P.A. Benton Arkansas United States 72019
    3 The Children's Clinic of Jonesboro, P.A. Jonesboro Arkansas United States 72401
    4 Arkansas Children's Hospital Research Institute Little Rock Arkansas United States 72205
    5 Arkansas Pediatric Clinic Little Rock Arkansas United States 72205
    6 Little Rock Children's Clinic Little Rock Arkansas United States 72205
    7 Miller Children's Hospital Long Beach California United States 90806
    8 Children's Hospital of Oakland Oakland California United States 94609
    9 Children's Hospital of Orange County Orange California United States 92868
    10 Children's Hospital Denver Colorado United States 82018
    11 Pediatric Pulmonology, LLC Stamford Connecticut United States 06902
    12 Shands Hospital at the University of Florida Gainesville Florida United States 32610
    13 University of Miami Medical Center Miami Florida United States 33136
    14 University of South Florida Pediatrics Ambulatory Care Center Tampa Florida United States 33136
    15 Georgia Pediatric Pulmonology Associates Atlanta Georgia United States 30342
    16 Kapiolani Medical Center Honolulu Hawaii United States 96826
    17 University of Illinois at Chicago Chicago Illinois United States 60612
    18 Children's Memorial Hospital Chicago Illinois United States 60614
    19 Memorial Hospital of South Bend South Bend Indiana United States 46601
    20 University of Maryland, School of Medicine Baltimore Maryland United States 21201
    21 Tufts-New England Medical Center Boston Massachusetts United States 02111
    22 Boston Medical Center Boston Massachusetts United States 02118
    23 Children's Healthcare D.B.A. Hospitals & Clinics St. Paul Minnesota United States 55102
    24 Pediatrix Medical Group, St. John's Mercy Medical Center St. Louis Missouri United States 63141
    25 Midwest Children's Health Research Institute, LLC Lincoln Nebraska United States 68505
    26 Creighton University Medical Center Omaha Nebraska United States 68198
    27 Albany Medical Center Albany New York United States 12208
    28 Bronx-Lebanon Hospital Center Bronx New York United States 10457
    29 Jacobi Medical Center Bronx New York United States 10461
    30 Montefiore Medical Center Bronx New York United States 10467
    31 Winthrop University Hospital Mineola New York United States 11501
    32 University of Rochester Medical Center Rochester New York United States 14624
    33 University Hospital, State University of New York at Stony Brook Stony Brook New York United States 11794
    34 Crouse Hospital NICU Syracuse New York United States 13210
    35 Carolinas Medical Center Charlotte North Carolina United States 28203
    36 Duke University Medical Center Durham North Carolina United States 27710
    37 Raleigh Pediatric Associates Gardner North Carolina United States 27529
    38 Raleigh Pediatric Associates Raleigh North Carolina United States 27615
    39 Children's Hospital Medical Center of Akron Akron Ohio United States 44308
    40 Beehly Medical Park Women's and Children's Pavilion Boardman Ohio United States 44512
    41 University of Cincinnati College of Medicine Cincinnati Ohio United States 45267
    42 Metro Health Medical Center Cleveland Ohio United States 44109
    43 Children's Medical Center Dayton Ohio United States 45404
    44 Pediatric Associates of Dayton, Inc. Kettering Ohio United States 45429
    45 St. Vincent Medical Center Toledo Ohio United States 43608
    46 Oregon Health & Science University Portland Oregon United States 97239
    47 St. Luke's Hospital Bethlehem Pennsylvania United States 18015
    48 Geisinger Medical Center - JW Children's Hospital Danville Pennsylvania United States 17822
    49 Pennsylvania Hospital Philadelphia Pennsylvania United States 19017
    50 Children's Hospital of Pittsburgh Pittsburgh Pennsylvania United States 15213
    51 Rhode Island Hospital Providence Rhode Island United States 02903
    52 Driscoll Children's Hospital Corpus Christi Texas United States 78414
    53 University of Texas Southwestern Medical Center Dallas Texas United States 75390
    54 University of Texas Houston Medical Center Houston Texas United States 77030
    55 VCU Medical Center, Children's Pavillion Richmond Virginia United States 23298
    56 University Physicians Internal Medicine Huntington West Virginia United States 25701
    57 West Virginia University Morgantown West Virginia United States 26506
    58 Children's Hospital Waukesha Memorial Waukesha Wisconsin United States 53118
    59 Children's Corporate Center Wauwatosa Wisconsin United States 53226

    Sponsors and Collaborators

    • MedImmune LLC

    Investigators

    • Study Director: Frank Malinoski, M.D., PhD, MedImmune LLC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00384462
    Other Study ID Numbers:
    • MI-MA140
    First Posted:
    Oct 6, 2006
    Last Update Posted:
    Feb 4, 2009
    Last Verified:
    Feb 1, 2009

    Study Results

    No Results Posted as of Feb 4, 2009